166 related articles for article (PubMed ID: 37777989)
21. Effects of indole-3-carbinol on lung tumorigenesis and DNA methylation induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and on the metabolism and disposition of NNK in A/J mice.
Morse MA; LaGreca SD; Amin SG; Chung FL
Cancer Res; 1990 May; 50(9):2613-7. PubMed ID: 2328487
[TBL] [Abstract][Full Text] [Related]
22. Identification of cytochrome P450 enzymes critical for lung tumorigenesis by the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK): insights from a novel Cyp2abfgs-null mouse.
Li L; Megaraj V; Wei Y; Ding X
Carcinogenesis; 2014 Nov; 35(11):2584-91. PubMed ID: 25173884
[TBL] [Abstract][Full Text] [Related]
23. Development of ferret as a human lung cancer model by injecting 4-(Nmethyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
Aizawa K; Liu C; Veeramachaneni S; Hu KQ; Smith DE; Wang XD
Lung Cancer; 2013 Dec; 82(3):390-6. PubMed ID: 24396883
[TBL] [Abstract][Full Text] [Related]
24. Cucurbitacin B Alters the Expression of Tumor-Related Genes by Epigenetic Modifications in NSCLC and Inhibits NNK-Induced Lung Tumorigenesis.
Shukla S; Khan S; Kumar S; Sinha S; Farhan M; Bora HK; Maurya R; Meeran SM
Cancer Prev Res (Phila); 2015 Jun; 8(6):552-62. PubMed ID: 25813524
[TBL] [Abstract][Full Text] [Related]
25. Differential involvement of gp130 signalling pathways in modulating tobacco carcinogen-induced lung tumourigenesis.
Miller A; Brooks GD; McLeod L; Ruwanpura S; Jenkins BJ
Oncogene; 2015 Mar; 34(12):1510-9. PubMed ID: 24727895
[TBL] [Abstract][Full Text] [Related]
26. Tobacco specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone suppresses a newly identified anti-tumor IGFBP-3/IGFBP-3R system in lung cancer cells.
Harada A; Jogie-Brahim S; Oh Y
Lung Cancer; 2013 Jun; 80(3):270-7. PubMed ID: 23498137
[TBL] [Abstract][Full Text] [Related]
27. Chronic exposure of lung alveolar epithelial type II cells to tobacco-specific carcinogen NNK results in malignant transformation: a new in vitro lung carcinogenesis model.
Mennecier G; Torres LN; Cogliati B; Sanches DS; Mori CM; Latorre AO; Chaible LM; Mackowiak II; Nagamine MK; Da Silva TC; Fukumasu H; Dagli ML
Mol Carcinog; 2014 May; 53(5):392-402. PubMed ID: 23203541
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of CRM1: A Characteristic Feature in a Transformed Phenotype of Lung Carcinogenesis and a Molecular Target for Lung Cancer Adjuvant Therapy.
Gao W; Lu C; Chen L; Keohavong P
J Thorac Oncol; 2015 May; 10(5):815-825. PubMed ID: 25629636
[TBL] [Abstract][Full Text] [Related]
29. Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines.
Rivenson A; Hoffmann D; Prokopczyk B; Amin S; Hecht SS
Cancer Res; 1988 Dec; 48(23):6912-7. PubMed ID: 3180100
[TBL] [Abstract][Full Text] [Related]
30. [FHIT protein expression during malignant transformation of human bronchial epithelial cells induced by NNK].
Kong L; Wu Q; Zhu J
Zhongguo Fei Ai Za Zhi; 2006 Apr; 9(2):167-72. PubMed ID: 21144304
[TBL] [Abstract][Full Text] [Related]
31. Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induces phosphorylation of mu- and m-calpain in association with increased secretion, cell migration, and invasion.
Xu L; Deng X
J Biol Chem; 2004 Dec; 279(51):53683-90. PubMed ID: 15471877
[TBL] [Abstract][Full Text] [Related]
32. Reciprocal effects of NNK and SLURP-1 on oncogene expression in target epithelial cells.
Kalantari-Dehaghi M; Bernard HU; Grando SA
Life Sci; 2012 Nov; 91(21-22):1122-5. PubMed ID: 22369755
[TBL] [Abstract][Full Text] [Related]
33. Transformation of non-cancerous human breast epithelial cell line MCF10A by the tobacco-specific carcinogen NNK.
Mei J; Hu H; McEntee M; Plummer H; Song P; Wang HC
Breast Cancer Res Treat; 2003 May; 79(1):95-105. PubMed ID: 12779086
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of microRNAs in early-stage neoplastic transformation in the lungs of F344 rats chronically treated with the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
Kalscheuer S; Zhang X; Zeng Y; Upadhyaya P
Carcinogenesis; 2008 Dec; 29(12):2394-9. PubMed ID: 18780894
[TBL] [Abstract][Full Text] [Related]
35. Understanding tobacco smoke carcinogen NNK and lung tumorigenesis.
Akopyan G; Bonavida B
Int J Oncol; 2006 Oct; 29(4):745-52. PubMed ID: 16964372
[TBL] [Abstract][Full Text] [Related]
36. Evidence for an important role of DNA pyridyloxobutylation in rat lung carcinogenesis by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone: effects of dose and phenethyl isothiocyanate.
Staretz ME; Foiles PG; Miglietta LM; Hecht SS
Cancer Res; 1997 Jan; 57(2):259-66. PubMed ID: 9000565
[TBL] [Abstract][Full Text] [Related]
37. Chemopreventive efficacy of suberoylanilide hydroxamic acid (SAHA) against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis in female A/J mice.
Desai D; Das A; Cohen L; el-Bayoumy K; Amin S
Anticancer Res; 2003; 23(1A):499-503. PubMed ID: 12680257
[TBL] [Abstract][Full Text] [Related]
38. NNK, a tobacco-specific carcinogen, inhibits the expression of lysyl oxidase, a tumor suppressor.
Cheng G; Li J; Zheng M; Zhao Y; Zhou J; Li W
Int J Environ Res Public Health; 2014 Dec; 12(1):64-82. PubMed ID: 25546273
[TBL] [Abstract][Full Text] [Related]
39. Nicotinic receptor-mediated activation by the tobacco-specific nitrosamine NNK of a Raf-1/MAP kinase pathway, resulting in phosphorylation of c-myc in human small cell lung carcinoma cells and pulmonary neuroendocrine cells.
Jull BA; Plummer HK; Schuller HM
J Cancer Res Clin Oncol; 2001 Dec; 127(12):707-17. PubMed ID: 11768610
[TBL] [Abstract][Full Text] [Related]
40. The tobacco carcinogen NNK disturbs mitotic chromosome alignment by interrupting p53 targeting to the centrosome.
Park JE; Jang YL; Jang CY
Toxicol Lett; 2017 Nov; 281():110-118. PubMed ID: 28964810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
